Tinea Capitis in Children Younger than Two Years Old: A Retrospective Study and Treatment Recommendations
- PMID: 36581775
- DOI: 10.1007/s11046-022-00703-z
Tinea Capitis in Children Younger than Two Years Old: A Retrospective Study and Treatment Recommendations
Abstract
Background: Tinea capitis (TC) is a dermatophytosis of the scalp and hair, which occurs less common in children younger than two years of age, and the data of TC in this age group are still unknown.
Objectives: We aimed to reveal the epidemiological, clinical and mycological characteristics of TC in children under two years old.
Methods: We retrospectively analyzed all reported cases of TC in children in their first two years of life from 1991 to 2022, by searching PubMed, Embase, Web of Science, CNKI, Wanfang and Weipu databases.
Results: A total of 47 articles involving 126 cases of pediatric TC were enrolled in this study. The sex ratio (M/F) was 1.28:1. The age of the children ranged from ten days old to two years old with a median age of three months. The main clinical manifestations were alopecic patches (40 cases, 31.7%) and scaling (39 cases, 31.0%) on the scalp, and 29 infants (23.0%) appeared kerion. The most common sources of contagion were animals (35 cases, 27.78%) and humans (31 cases, 24.60%). The leading pathogens were Microsporidium canis (64 cases, 50.79%), followed by Trichophyton violaceum (13 cases, 10.32%), T. mentagrophytes complex (12 cases, 9.52%) and T. tonsurans (10 cases, 7.94%). Ninety-five children (75.40%) were treated with systemic antifungal drugs and 22 patients (17.46%) were only treated with topical therapy. Except for 10 patients with unknown final prognosis, all the other cases were cured after treatment. There was one child (0.79%) relapsed after treatment with griseofulvin and one case (0.79%) presented with gastrointestinal symptoms from griseofulvin.
Conclusion: The principal clinical symptoms of TC in children less than two years old were alopecic patches and scaling. The top four pathogens were M. canis, T. violaceum, T. mentagrophytes complex and T. tonsurans. Oral treatment for pediatric TC had achieved good therapeutic effects, and topical therapy can be an alternative choice.
Keywords: Children younger than two years old; Dermatophyte; Dermatophytosis; Tinea capitis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Letter: Tinea capitis in infants in their first 2 years of life: A 12-year study and a review of the literature.Dermatol Online J. 2012 Jul 15;18(7):16. Dermatol Online J. 2012. PMID: 22863638 Review.
-
Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.Int J Dermatol. 2019 Aug;58(8):912-915. doi: 10.1111/ijd.14352. Epub 2018 Dec 13. Int J Dermatol. 2019. PMID: 30548845
-
Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.Mycopathologia. 2023 Oct;188(5):449-460. doi: 10.1007/s11046-022-00657-2. Epub 2022 Aug 18. Mycopathologia. 2023. PMID: 35980496
-
Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.Med Mycol. 2017 Jul 1;55(5):476-484. doi: 10.1093/mmy/myw107. Med Mycol. 2017. PMID: 27744309
-
Tinea capitis in infants in their first year of life.Br J Dermatol. 2004 Oct;151(4):886-90. doi: 10.1111/j.1365-2133.2004.06112.x. Br J Dermatol. 2004. PMID: 15491432 Review.
Cited by
-
Tinea capitis (Favus) in a 8-year-old child: Case report.Clin Case Rep. 2024 Jul 29;12(8):e9174. doi: 10.1002/ccr3.9174. eCollection 2024 Aug. Clin Case Rep. 2024. PMID: 39081825 Free PMC article.
-
Successful treatment of fungal ball-associated tinea capitis in a healthy infant: An unusual presentation.Clin Case Rep. 2023 Jul 30;11(8):e7752. doi: 10.1002/ccr3.7752. eCollection 2023 Aug. Clin Case Rep. 2023. PMID: 37529136 Free PMC article.
References
-
- Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58–68. https://doi.org/10.2174/1872213x14666200106145624 . - DOI - PubMed
-
- Mandras N, Roana J, Cervetti O, Panzone M, Tullio V. A case report of tinea capitis in infant in first year of life. BMC Pediatr. 2019;19(1):65. https://doi.org/10.1186/s12887-019-1433-7 . - DOI - PubMed - PMC
-
- Toyosawa Y, Kimura U, Kurihara M, Noguchi H, Matsumoto T, Hiruma M, et al. Kerion Celsi caused by nannizzia gypsea in a two-year-old child who had been hospitalized since birth. Med Mycol J. 2022;63(1):21–3. https://doi.org/10.3314/mmj.21-00021 . - DOI - PubMed
-
- Zampella JG, Kwatra SG, Blanck J, Cohen B. Tinea in tots: cases and literature review of oral antifungal treatment of tinea capitis in children under 2 years of age. J Pediatr. 2017;183:12-8.e3. https://doi.org/10.1016/j.jpeds.2016.12.042 . - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 2021-I2M-1-039/CAMS Innovation Fund for Medical Sciences (CIFMS)
- NPRC-32/The National Science and Technology Infrastructure of China
- 2021-PT310-006/The Basic Scientific Research Fund Projects of Chinese Academy of Medical Sciences
- 81972949/National Natural Science Foundation of China
- 3332020060/Peking Union Medical College, Fundamental Research Funds for the Central Universities
LinkOut - more resources
Full Text Sources